Verition Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Buy |
21,802
+1,678
| +8% | +$881K | 0.05% | 408 |
|
2025
Q1 | $12.8M | Sell |
20,124
-6,187
| -24% | -$3.92M | 0.06% | 337 |
|
2024
Q4 | $18.7M | Buy |
26,311
+25,257
| +2,396% | +$18M | 0.07% | 229 |
|
2024
Q3 | $1.11M | Sell |
1,054
-7,499
| -88% | -$7.88M | 0.01% | 1270 |
|
2024
Q2 | $8.99M | Sell |
8,553
-4,679
| -35% | -$4.92M | 0.05% | 340 |
|
2024
Q1 | $12.7M | Buy |
13,232
+8,451
| +177% | +$8.13M | 0.09% | 196 |
|
2023
Q4 | $4.2M | Buy |
+4,781
| New | +$4.2M | 0.03% | 454 |
|
2023
Q3 | – | Sell |
-765
| Closed | -$550K | – | 2218 |
|
2023
Q2 | $550K | Buy |
765
+34
| +5% | +$24.4K | 0.01% | 1019 |
|
2023
Q1 | $601K | Sell |
731
-12,941
| -95% | -$10.6M | 0.01% | 1042 |
|
2022
Q4 | $9.86M | Buy |
13,672
+12,986
| +1,893% | +$9.37M | 0.15% | 133 |
|
2022
Q3 | $473K | Sell |
686
-1,194
| -64% | -$823K | 0.01% | 1522 |
|
2022
Q2 | $1.11M | Buy |
1,880
+1,322
| +237% | +$782K | 0.02% | 934 |
|
2022
Q1 | $390K | Sell |
558
-465
| -45% | -$325K | ﹤0.01% | 1353 |
|
2021
Q4 | $646K | Sell |
1,023
-459
| -31% | -$290K | ﹤0.01% | 1077 |
|
2021
Q3 | $897K | Sell |
1,482
-779
| -34% | -$472K | 0.01% | 754 |
|
2021
Q2 | $1.26M | Buy |
+2,261
| New | +$1.26M | 0.01% | 601 |
|
2020
Q4 | – | Sell |
-755
| Closed | -$423K | – | 1236 |
|
2020
Q3 | $423K | Sell |
755
-144
| -16% | -$80.7K | 0.01% | 563 |
|
2020
Q2 | $561K | Buy |
+899
| New | +$561K | 0.02% | 504 |
|
2020
Q1 | – | Sell |
-3,528
| Closed | -$1.33M | – | 863 |
|
2019
Q4 | $1.33M | Sell |
3,528
-9,403
| -73% | -$3.53M | 0.02% | 291 |
|
2019
Q3 | $3.59M | Buy |
12,931
+2,437
| +23% | +$676K | 0.1% | 98 |
|
2019
Q2 | $3.29M | Buy |
10,494
+9,519
| +976% | +$2.98M | 0.09% | 118 |
|
2019
Q1 | $400K | Buy |
+975
| New | +$400K | 0.02% | 671 |
|
2018
Q4 | – | Sell |
-3,682
| Closed | -$1.49M | – | 1086 |
|
2018
Q3 | $1.49M | Buy |
+3,682
| New | +$1.49M | 0.05% | 389 |
|
2018
Q1 | – | Sell |
-1,835
| Closed | -$690K | – | 1220 |
|
2017
Q4 | $690K | Sell |
1,835
-88
| -5% | -$33.1K | 0.06% | 337 |
|
2017
Q3 | $860K | Buy |
1,923
+8
| +0.4% | +$3.58K | 0.07% | 312 |
|
2017
Q2 | $941K | Buy |
1,915
+1,126
| +143% | +$553K | 0.09% | 174 |
|
2017
Q1 | $306K | Sell |
789
-1,829
| -70% | -$709K | 0.03% | 779 |
|
2016
Q4 | $961K | Buy |
+2,618
| New | +$961K | 0.08% | 244 |
|
2016
Q3 | – | Sell |
-4,885
| Closed | -$1.71M | – | 1177 |
|
2016
Q2 | $1.71M | Buy |
4,885
+2,405
| +97% | +$840K | 0.22% | 77 |
|
2016
Q1 | $894K | Buy |
2,480
+1,868
| +305% | +$673K | 0.14% | 134 |
|
2015
Q4 | $332K | Buy |
612
+128
| +26% | +$69.4K | 0.06% | 263 |
|
2015
Q3 | $225K | Buy |
+484
| New | +$225K | 0.06% | 415 |
|
2015
Q1 | – | Sell |
-514
| Closed | -$211K | – | 461 |
|
2014
Q4 | $211K | Sell |
514
-331
| -39% | -$136K | 0.05% | 219 |
|
2014
Q3 | $305K | Sell |
845
-3,540
| -81% | -$1.28M | 0.04% | 368 |
|
2014
Q2 | $1.24M | Buy |
4,385
+2,173
| +98% | +$614K | 0.13% | 81 |
|
2014
Q1 | $664K | Buy |
2,212
+1,257
| +132% | +$377K | 0.1% | 116 |
|
2013
Q4 | $263K | Sell |
955
-2,109
| -69% | -$581K | 0.05% | 285 |
|
2013
Q3 | $959K | Buy |
3,064
+343
| +13% | +$107K | 0.15% | 101 |
|
2013
Q2 | $612K | Buy |
+2,721
| New | +$612K | 0.11% | 160 |
|